Surgical Innovation Associates
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Surgical Innovation Associates, a 2016 Northwestern University spin-out based in Chicago, developed DuraSorb, a resorbable synthetic polydioxanone mesh for plastic and reconstructive surgery. The monofilament mesh supports soft tissue during early wound healing and is gradually resorbed within about a year, avoiding complications of permanent implants. The product won FDA 510(k) clearance in 2018 and a CE mark in 2019. In December 2022 Integra LifeSciences agreed to acquire the company for $140 million in total deal value.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Surgical Innovation Associates is founded in Chicago as a Northwestern spin-out by Alexei Mlodinow, Todd Cruikshank and plastic surgeon John Kim.
- Peak funding round
The company closes an oversubscribed $15 million Series B round.
- Acquisition
On December 1, 2022, Integra LifeSciences announces a definitive agreement to acquire the company for $140 million in total deal value.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.